These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12411752)

  • 21. Contrast nephropathy after coronary angiography.
    Gami AS; Garovic VD
    Mayo Clin Proc; 2004 Feb; 79(2):211-9. PubMed ID: 14959916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.
    Wang A; Holcslaw T; Bashore TM; Freed MI; Miller D; Rudnick MR; Szerlip H; Thames MD; Davidson CJ; Shusterman N; Schwab SJ
    Kidney Int; 2000 Apr; 57(4):1675-80. PubMed ID: 10760103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram.
    Rahman MM; Haque SS; Rokeya B; Siddique MA; Banerjee SK; Ahsan SA; Rahman F; Mahmood M; Ahmed K; Bhuiyan MM; Joarder AI; Debnath RC
    Mymensingh Med J; 2012 Apr; 21(2):292-9. PubMed ID: 22561774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Contrast-media-induced nephrotoxicity].
    Adolph E; Chatterjee T; Ince H; Eckard H; Rehders T; Kische S; Drawert S; Petzsch M; Nienaber CA
    Dtsch Med Wochenschr; 2005 Oct; 130(42):2391-6. PubMed ID: 16235148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
    Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast nephropathy, cardiology and the newer radiocontrast agents.
    Taliercio CP; Burnett JC
    Int J Cardiol; 1988 May; 19(2):145-51. PubMed ID: 3286534
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy.
    Barlak A; Akar H; Yenicerioglu Y; Yenisey C; Meteoğlu I; Yilmaz O
    Ren Fail; 2010; 32(8):992-9. PubMed ID: 20722568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of bicarbonate versus saline infusion for iso- and lowosmolar contrast media in rats.
    Ladwig M; Flemming B; Seeliger E; Sargsyan L; Persson PB
    Invest Radiol; 2011 Nov; 46(11):672-7. PubMed ID: 21623210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An easy and effective procedure to prevent radiocontrast agent nephrotoxicity in high-risk patients.
    Teruel JL; Marcen R; Herrero JA; Felipe C; Ortuño J
    Nephron; 1989; 51(2):282. PubMed ID: 2915771
    [No Abstract]   [Full Text] [Related]  

  • 30. [Nephrotoxicity of contrast media--etiopathogenesis and methods of prevention].
    Kolonko A; Wiecek A; Kokot F
    Postepy Hig Med Dosw; 1996; 50(3):245-63. PubMed ID: 8927585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What is the best treatment to prevent radiocontrast nephropathy in cirrhotic patients?].
    Barrière E
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1211-2. PubMed ID: 16518273
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylactic 0.9% saline hydration inhibited high-dose gadodiamide-induced nephropathy in rats.
    Chien CC; Sheu MJ; Chu CC; Sun YM; Kan WC; Wang HY; Hwang JC; Wang JJ
    Hum Exp Toxicol; 2012 Nov; 31(11):1170-8. PubMed ID: 22736251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.
    Koc F; Ozdemir K; Altunkas F; Celik A; Dogdu O; Karayakali M; Gul EE; Erkorkmaz U; Kadi H; Akpek M; Kaya MG
    J Investig Med; 2013 Jun; 61(5):872-7. PubMed ID: 23552179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evidence-based approach to minimise contrast-induced nephropathy.
    Darwish T
    N Z Med J; 2009 Jul; 122(1299):39-41. PubMed ID: 19684646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bicarbonate in the prevention of iodinated contrast medium-induced kidney damage: a never-ending story?].
    Fiaccadori E
    G Ital Nefrol; 2010; 27(3):218. PubMed ID: 20540011
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of fenoldopam for prevention of radiocontrast nephropathy in the cardiac catheterization laboratory: a case series.
    Madyoon H; Croushore L
    J Interv Cardiol; 2001 Apr; 14(2):179-85. PubMed ID: 12053301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy.
    Jacobs F
    N Engl J Med; 2004 Feb; 350(8):836-8; author reply 836-8. PubMed ID: 14978835
    [No Abstract]   [Full Text] [Related]  

  • 38. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version.
    JSN, JRS and JCS Joint Working Group
    Circ J; 2013; 77(7):1883-914. PubMed ID: 23803256
    [No Abstract]   [Full Text] [Related]  

  • 39. [Protecting kidneys from radiocontrast toxicity--do fluids or drugs help?].
    Aitio ML
    Duodecim; 1999; 115(19):2075-84. PubMed ID: 11941801
    [No Abstract]   [Full Text] [Related]  

  • 40. [Review of the radiocontrast nephropathy risk profiles and risk stratification].
    Toprak O; Cirit M; Bayata S; Yeşil M
    Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.